The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
- PMID: 34621267
- PMCID: PMC8490747
- DOI: 10.3389/fimmu.2021.718220
The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Abstract
A large and expending body of evidence indicates that the gut-brain axis likely plays a crucial role in neurological diseases, including multiple sclerosis (MS). As a whole, the gut-brain axis can be considered as a bi-directional multi-crosstalk pathway that governs the interaction between the gut microbiota and the organism. Perturbation in the commensal microbial population, referred to as dysbiosis, is frequently associated with an increased intestinal permeability, or "leaky gut", which allows the entrance of exogeneous molecules, in particular bacterial products and metabolites, that can disrupt tissue homeostasis and induce inflammation, promoting both local and systemic immune responses. An altered gut microbiota could therefore have significant repercussions not only on immune responses in the gut but also in distal effector immune sites such as the CNS. Indeed, the dysregulation of this bi-directional communication as a consequence of dysbiosis has been implicated as playing a possible role in the pathogenesis of neurological diseases. In multiple sclerosis (MS), the gut-brain axis is increasingly being considered as playing a crucial role in its pathogenesis, with a major focus on specific gut microbiota alterations associated with the disease. In both MS and its purported murine model, experimental autoimmune encephalomyelitis (EAE), gastrointestinal symptoms and/or an altered gut microbiota have been reported together with increased intestinal permeability. In both EAE and MS, specific components of the microbiota have been shown to modulate both effector and regulatory T-cell responses and therefore disease progression, and EAE experiments with germ-free and specific pathogen-free mice transferred with microbiota associated or not with disease have clearly demonstrated the possible role of the microbiota in disease pathogenesis and/or progression. Here, we review the evidence that can point to two possible consequences of the gut-brain axis dysfunction in MS and EAE: 1. A pro-inflammatory intestinal environment and "leaky" gut induced by dysbiosis could lead to an altered communication with the CNS through the cholinergic afferent fibers, thereby contributing to CNS inflammation and disease pathogenesis; and 2. Neuroinflammation affecting efferent cholinergic transmission could result in intestinal inflammation as disease progresses.
Keywords: dysbiosis; enteric nervous system; experimental autoimmune encephalomyelitis; intestinal permeability; neuroinflammation; probiotics; short-chain fatty acids (SCFA); vagus nerve.
Copyright © 2021 Parodi and Kerlero de Rosbo.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.Int J Mol Sci. 2023 Sep 29;24(19):14756. doi: 10.3390/ijms241914756. Int J Mol Sci. 2023. PMID: 37834203 Free PMC article. Review.
-
Oxymatrine ameliorates experimental autoimmune encephalomyelitis by rebalancing the homeostasis of gut microbiota and reducing blood-brain barrier disruption.Front Cell Infect Microbiol. 2023 Jan 12;12:1095053. doi: 10.3389/fcimb.2022.1095053. eCollection 2022. Front Cell Infect Microbiol. 2023. PMID: 36710971 Free PMC article.
-
The second brain: The connection between gut microbiota composition and multiple sclerosis.J Neuroimmunol. 2021 Nov 15;360:577700. doi: 10.1016/j.jneuroim.2021.577700. Epub 2021 Aug 24. J Neuroimmunol. 2021. PMID: 34482269 Review.
-
The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders.Immunology. 2018 Jun;154(2):178-185. doi: 10.1111/imm.12903. Epub 2018 Feb 27. Immunology. 2018. PMID: 29392733 Free PMC article. Review.
-
The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.Microbiol Spectr. 2015 Jun;3(3). doi: 10.1128/microbiolspec.MBP-0008-2014. Microbiol Spectr. 2015. PMID: 26185088
Cited by
-
Improvements in Gut Microbiome Composition and Clinical Symptoms Following Familial Fecal Microbiota Transplantation in a Nineteen-Year-Old Adolescent With Severe Autism.J Med Cases. 2024 May;15(4-5):82-91. doi: 10.14740/jmc4209. Epub 2024 May 2. J Med Cases. 2024. PMID: 38715916 Free PMC article.
-
Applied physiology: gut microbiota and antimicrobial therapy.Eur J Appl Physiol. 2024 Jun;124(6):1631-1643. doi: 10.1007/s00421-024-05496-1. Epub 2024 Apr 29. Eur J Appl Physiol. 2024. PMID: 38683402 Review.
-
In-silico characterization of GABAT protein found in gut-brain axis associated bacteria of healthy individuals and multiple sclerosis patients.Saudi J Biol Sci. 2024 Apr;31(4):103939. doi: 10.1016/j.sjbs.2024.103939. Epub 2024 Feb 2. Saudi J Biol Sci. 2024. PMID: 38352114 Free PMC article.
-
Impact of Disease-Modifying Therapies on Gut-Brain Axis in Multiple Sclerosis.Medicina (Kaunas). 2023 Dec 20;60(1):6. doi: 10.3390/medicina60010006. Medicina (Kaunas). 2023. PMID: 38276041 Free PMC article. Review.
-
The Gut-Brain Axis in Autoimmune Diseases: Emerging Insights and Therapeutic Implications.Cureus. 2023 Nov 11;15(11):e48655. doi: 10.7759/cureus.48655. eCollection 2023 Nov. Cureus. 2023. PMID: 38090441 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials